The Journal of Pediatrics
Volume 151, Issue 3 , Pages 235-237 , September 2007

Acute Viral Bronchiolitis: To Treat or Not to Treat—That Is the Question

  • Claudia Calogero, MD

      Affiliations

    • Telethon Institute for Child Health Research, Subiaco, WA, Australia, School of Pediatrics, University of Florence, Florence, Italy
    • ,
  • Peter D. Sly, MBBS, MD, DSC, FRACP

      Affiliations

    • Telethon Institute for Child Health Research, Subiaco, WA, Australia
    • Corresponding Author InformationReprint requests: Professor Peter Sly, Telethon Institute for Child Health Research, Division of Clinical Sciences 100 Roberts Rd, Subiaco, WA6008, Australia.

References 

  1. Sly PD, Collins RA. Physiological basis of respiratory signs and symptoms. Paediatr Respir Rev. 2006;7:84–88
  2. Everard ML. Acute viral bronchiolitis and pneumonia in infancy resulting from the respiratory syncytial virus. In:  Taussig LM,  Landau LI,  Le Souef PN,  Morgan WJ,  Martinez FD,  Sly PD editor. Pediatric respiratory medicine. St. Louis: Mosby; 1999;p. 580–595
  3. Henderson FW, Clyde WJ, Collier AM. The etiologic and epidemiologic spectrum of bronchiolitis in pediatric practice. J Pediatr. 1979;95:183–190
  4. Kim H, Arrobio J, Brandt C. Epidemiology of respiratory syncytial virus infection in Washington, DC, importance of the virus in different disease syndromes and temporal distribution of infection. Am J Epidemiol. 1973;98:216–225
  5. Abzug M, Beam A, Gyorkos E, Levin M. Viral pneumonia in the first of month of life. Pediatr Infect Dis J. 1990;9:881–885
  6. Sly PD, Hibbert ME. Childhood asthma following hospitalization with acute viral bronchiolitis in infancy. Pediatr Pulmonol. 1989;7:153–158
  7. Stein RT, Sherrill D, Morgan WJ, Holberg CJ, Halonen M, Taussig LM, et al. Respiratory syncytial virus in early life and risk of wheeze and allergy by age 13 years. Lancet. 1999;354:541–545
  8. Pullan CR, Hey EN. Wheezing, asthma and pulmonary dysfunction 10 years after infection with respiratory syncytial virus in infancy. Br Med J. 1982;284:1665–1669
  9. Welliver RC, Duffy L. The relationship of RSV-specific immunoglobulin E antibody responses in infancy, recurrent wheezing, and pulmonary function at age 7-8 years. Pediatr Pulmonol. 1993;15:19–27
  10. Kusel MMH, de Klerk NH, Holt PG, Kebadze T, Johnston SL, Sly PD. Role of respiratory viruses in acute upper and lower respiratory tract illness in the first year of life a birth cohort study. Pediatr Infect Dis J. 2006;25:680–686
  11. Lemanske RF, Jackson DJ, Gangnon RE, Evans MD, Li Z, Shult PA, et al. Rhinovirus illness during infancy predicts subsequent childhood wheezing. J Allergy Clin Immunol. 2005;116:571–577
  12. Young S, O’Keeffe PT, Arnott J, Landau LI. Lung function, airway responsiveness, and respiratory symptoms before and after bronchiolitis. Arch Dis Child. 1995;72:16–24
  13. Martinez FD, Wright AL, Taussig LM, Holberg CJ, Halonen M, Morgan WJ. Asthma and wheezing in the first six years of life. N Eng J Med. 1995;332:133–138
  14. Macaubas C, de Klerk N, Holt BJ, Wee C, Kendall G, Firth M, et al. Association between antenatal cytokine production and the development of atopy and asthma at age 6 years. Lancet. 2003;362:1192–1197
  15. Rowe J, Macaubas C, Monger T, Holt BJ, Harvey J, Poolman JT, et al. Heterogeneity in diptheria-tetanus-acellular pertussis vaccine-specific cellular immunity during infancy: relationship to variations in the kinetics of postnatal maturation of systematic Th1 function. J Infect Dis. 2001;184:80–88
  16. Stang P, Brandenburg N, Carter B. The economic burden of respiratory syncytial virus-associated bronchiolitis hospitalizations. Arch Ped Adolesc Med. 2001;155:95–96
  17. Mullins JA, Lamonte AC, Bresee JS, Anderson LJ. Substantial variability in community respiratory syncytial virus season timing. Pediatr Infect Dis J. 2003;22:857–886
  18. Leader S, Kohlhase K. Recent trends in severe respiratory syncytial virus (RSV) among US infants, 1997-2000. J Pediatr. 2003;143:S127–S132
  19. Soto ME, Sly PD, Uren E, Taussig LM, Landau LI. Bronchodilator response during acute viral bronchiolitis in infancy. Pediatr Pulmonol. 1985;2:85–90
  20. Hughes DM, LeSouef PN, Landau LI. Effect of salbutamol on respiratory mechanics in bronchiolitis. Pediatr Res. 1987;22:83–88
  21. O’Callaghan C, Milner AD, Swarbnick A. Paradoxical deterioration in lung function after nebulised salbutamol in wheezy infants. Lancet. 1988;2:1424–1425
  22. Prendiville A, Green A, Silverman M. Paradoxical response to nebulised salbutamol, assessed by partial expiratory flow volume curves. Thorax. 1987;42:81–91
  23. Mallol J, Hibbert ME, Robertson CF, Olinsky A, Phelan PD, Sly PD. Inherent variability of pulmonary function tests in infants with bronchiolitis. Pediatr Pulmonol. 1988;5:152–157
  24. Ho L, Collis G, Landau LI, LeSouef PN. Effects of salbutamol on oxygen saturation in bronchiolitis. Arch Dis Child. 1991;60:1061–1064
  25. Mallol J, Barrueto L, Girardi G, Munoz R, Puppo H, Ulloa V, et al. Use of nebulised bronchodilators in infants under 1 year of age: analysis of four forms of therapy. Pediatr Pulmonol. 1987;3:298–303
  26. Wainwright C, Altimirano L, Cheney M, Cheney J, Barber S, Price D, et al. A multicenter, randomized, double-blind, controlled trial of nebulized epinephrine in infants with acute bronchiolitis. N Eng J Med. 2003;349:27–35
  27. Gadomski AM, Bhasale AL. Bronchodilators for bronchiolitis. Cochrane Database of Systematic Reviews. 2006;issue 3. Art No: CD001266. DOI: DOI: 10.1002/14651858.
  28. Subcommittee on diagnosis and management of bronchiolitis. Diagnosis and management of bronchiolitis. Pediatrics. 2006;118:1774–1793
  29. Dawson K, Kennedy D, Asher I, Cooper D, Cooper P, Francis P, et al. Consensus view: the management of acute bronchiolitis. J Paediatr Child Health. 1993;29:335–337
  30. Patel H, Platt R, Lorenzo JM, Wang EEL. Glucocorticoids for acute viral bronchiolitis in infants and young children. Cochrane Database of Systematic Reviews. 2004;issue 3. Art No: CD004878. DOI: DOI: 10.1002/14651858.
  31. Garrison MM, Christakis DA, Harvey E, Cummings P, Lavis RL. Systemic corticosteroids in infant bronchiolitis: a meta-analysis. Pediatrics. 2000;105:e44
  32. Blom D, Ermers M, Bont L, van Aaldren WMC, van Woensel JMB. Inhaled corticosteroids during acute bronchiolitis in the prevention of post-bronchiolitis wheezing. Cochrane Database of Systematic Reviews. 2007;issue 1. Art. No: CD004881. DOI: DOI: 10.1002/14651858.
  33. Kuzik BA, Al Qadhi SA, Kent S, Flavin MP, Hopman W, Hotte S, et al. Nebulized hypertonic saline in the treatment of viral bronchiolitis in infants. J Pediatr. 2007;151:266–270
  34. Bye PTP, Elkins MR. Mini-symposium: airway clearance in cystic fibrosis. Other mucoactive agents for cystic fibrosis. Pediatr Respir Rev. 2007;8:30–39
  35. Mandelberg A, Tal G, Witzling M, Someck E, Houri S, Balin A, et al. Nebulized 3% hypertonic saline solution treatment in hospitalized infants with viral bronchiolitis. Chest. 2003;123:481–487
  36. Sarrell EM, Tal G, Witzling M, Someck E, Houri S, Cohen HA, et al. Nebulized 3% hypertonic saline solution treatment in ambulatory children with viral bronchiolitis decreases symptoms. Chest. 2002;122:2015–2020

PII: S0022-3476(07)00492-1

doi: 10.1016/j.jpeds.2007.05.041

The Journal of Pediatrics
Volume 151, Issue 3 , Pages 235-237 , September 2007

Article Tools